Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Official Says Industry Should Pick up the Pace in Serializing Products

This article was originally published in The Gold Sheet

Executive Summary

Time is of the essence in complying with the serialization provisions of the Drug Supply Chain Security Act, warns Pfizer official. Too many manufacturers are waiting on the sidelines instead of getting these systems up and running before new serialization mandates go into effect in 2017.

You may also be interested in...



FDA's Beleaguered Criminal Investigations Unit Now Facing Congressional Scrutiny

After staff complain about becoming the 'Botox police,' a House committee is asking FDA for an update on two previous reports raising issues of management and morale in the Office of Criminal Investigations.

Pfizer To Begin Tagging All U.S. Viagra Shipments With RFID Chips By Dec. 15

Pfizer will start shipping all Viagra (sildenafil) for the U.S. market with radio frequency identification tags embedded at the case and individual item levels

Program Participants Urge The FDA To Adopt Some Pharmaceutical Quality Metrics And Avoid Others

Site-based metrics praised; lot acceptance rates, invalidated OOS rates discouraged. Agency official admits some proposed metrics were “not the best.”

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS000934

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel